Ranked the second-largest U.S. healthcare law firm by Modern Healthcare (2012)
Recognized as a top 10 law firm within the Life Sciences Regulatory Super League by The Practical Law Company (PLC) (2012)
Listed as Recommended in PLC's Life Sciences Multi-Jurisdictional Guide (2012)
- District of Columbia
- Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
M. Elizabeth Bierman is a partner in Morgan Lewis's FDA Practice. Ms. Bierman has more than 20 years of experience in representing domestic and international companies with respect to all FDA regulatory and compliance matters relating to the development, manufacturing, and marketing of medical devices, pharmaceuticals, biologicals, combination products, medical foods, and infant formulas.
Ms. Bierman has counseled extensively on jurisdictional issues and regulatory pathway strategies for FDA-regulated products; assisted clients in preparing medical device product applications, requests for designation, and other regulatory submissions; conducted FDA regulatory due diligence; and advised on medical device postmarket compliance issues (labeling/promotion, MDRs, recalls, QSR, responses to 483s, and Warning Letters). She also has advised clients on the regulatory requirements and emerging legal issues related to health information technology.
Ms. Bierman has spoken and taught at medical device industry conferences on the fundamentals of medical device law. She also has written articles for domestic and international publications regarding medical device and pharmaceutical regulatory issues.
Ms. Bierman received her J.D. from Catholic University of America, Columbus School of Law and her B.A. from the University of Virginia.
Ms. Bierman is admitted to practice in the District of Columbia.
- Catholic University of America, Columbus School of Law, 1986, J.D.
- University of Virginia, 1977, B.A.